[Acholangic cholestatic hepatitis evolving towards xanthomatosis and cirrhosis].
D001652:Bile Ducts / Q000473:pathology; D001663:Bilirubin / Q000097:blood; D001706:Biopsy; D001798:Blood Proteins / Q000032:analysis; D002779:Cholestasis / Q000150:complications*; D005260:Female; D005984:Glutethimide / Q000627:therapeutic use; D006505:Hepatitis / Q000150:complications* / Q000473:pathology; D006801:Humans; D006932:Hyperbilirubinemia / Q000209:etiology; D006949:Hyperlipidemias / Q000209:etiology; D008055:Lipids / Q000097:blood; D008103:Liver Cirrhosis / Q000209:etiology*; D008875:Middle Aged; D009336:Necrosis / Q000209:etiology; D010634:Phenobarbital / Q000627:therapeutic use; D011537:Pruritus / Q000188:drug therapy / Q000209:etiology; D014973:Xanthomatosis / Q000209:etiology*
D001798:Blood Proteins; D008055:Lipids; D005984:Glutethimide; D001663:Bilirubin; D010634:Phenobarbital
Hépatites cholestatiques acholangiques à évolution xanthomateuse et cirrhogène